MD. Available online at: http://seer.cancer.gov/csr/1975 2008/.
56.
Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003;17:643–650.
57.
Rome Foundation. Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. 2010. Available online at: http://www.
romecriteria.org/assets/pdf/19 RomeIII apA 885–898.pdf.
58.
Monnikes H, Schmidt BG, Tache Y. Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropinreleasing factor. Gastroenterology 1993;104;716–723.
59.
Heymann-Monnikes I, Arnold R, Florin I, et al. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 2000;95:981–994.
60.
Devault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reﬂux disease. Am J Gastroenterol 2005;100:190.
61.
Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association medical position statement on the management of gastroesophageal reﬂux disease. Gastroenterology 2008;135:1383.
62.
Moayyedi P, Soo S, Deeks JJ, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;2:CD002096.
63.
MacDermid JC, Wessel J. Clinical diagnosis of carpal tunnel syndrome: a systematic review. J Hand Ther 2004;17:309.
64.
Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral valve prolapsed. N Engl J Med 1999;341:1.
65.
Jacob G, Biaggioni I. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J MedSci 1999;317:88.
66.
Jacob G, Costa F, Shannon JR, et al. The neuropathic postural tachycardia syndrome. N Engl J Med 2000;343:1008.
67.
Raj SR, Biaggioni I, Yambure PC, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 2005;111:1574.
Phillip G. Stubblefield Danielle M. Roncari
The most common methods of contraception used in the United States are sterilization, oral contraceptives, and condoms, in that order.
Latex condoms and other barriers reduce the risk of sexually transmitted diseases (STDs) and cervical cancer.
The two intrauterine devices (IUDs) available in the United States, the copper T380A (ParaGard) and the levonorgestrel T (Mirena), are as effective as tubal sterilization and are associated with a long-term risk of pelvic infection that is no greater than that in the general population.
The combination estrogen–progestin oral contraceptive, patch, and vaginal ring all provide excellent contraception when used correctly but all increase the risk of venous thrombosis and thromboembolism.